2006
DOI: 10.1016/j.clpt.2006.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: Implications for drug exposure in renal allograft recipients

Abstract: This study demonstrates an interaction between mycophenolate mofetil and rifampin, which is a result of induction of MPA glucuronidation and possibly also rifampin-associated alterations in MRP2-mediated transport of MPAG and AcMPAG. This interaction should be taken into account when rifampin or other drugs influencing pregnane X receptor activity are coadministered with mycophenolate mofetil.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
51
0
3

Year Published

2007
2007
2015
2015

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 76 publications
(57 citation statements)
references
References 55 publications
(117 reference statements)
3
51
0
3
Order By: Relevance
“…Agents such as corticosteroids and rifampin (16), when introduced into the regimen, stimulate the biosynthesis of UGT, thereby increasing MPA clearance with consequent decreased MPA concentration. Discontinuation of such inducing drugs reduces MPA clearance and consequently increases MPA concentrations.…”
Section: Drug-drug Interactionsmentioning
confidence: 99%
“…Agents such as corticosteroids and rifampin (16), when introduced into the regimen, stimulate the biosynthesis of UGT, thereby increasing MPA clearance with consequent decreased MPA concentration. Discontinuation of such inducing drugs reduces MPA clearance and consequently increases MPA concentrations.…”
Section: Drug-drug Interactionsmentioning
confidence: 99%
“…However, a major concern of such a combination has been rifampin's ability to induce multiple drug-metabolizing enzymes and drug transporters, which results in the altered disposition of many coadministered drugs (24). Evidence exists that rifampin enhances the metabolism of UGT substrates, such as mycophenolic acid (23) and zidovudine (2,10). However, the effect of rifampin on the rate of N-glucuronidation of efavirenz remains unknown.…”
mentioning
confidence: 99%
“…Dette legemidlet bremser proliferasjonen av aktiverte lymfocytter ved å hemme syntesen av (deoksy)guaninnukleotider (29). Aktuelle legemiddelinteraksjoner for mykofenolat er oppsummert i tabell 2 (30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43).…”
Section: Mykofenolatunclassified
“…Det er også rapportert at tuberkulostatisk behandling med rifampicin medfører redusert mykofenolatnivå (36,37). Rifampicin induserer uttrykket av glukuronosyltransferaser slik at glukuronideringen av mykofenolat øker (36,46).…”
Section: Mykofenolatunclassified
See 1 more Smart Citation